Skip to content

Laser Therapy and Temporomandibular Disorders

Clinical Effectiveness of a Laser Therapy in Patients With Temporomandibular Disorders (A Randomized Clinical Trial)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05620758
Enrollment
50
Registered
2022-11-17
Start date
2022-11-30
Completion date
2023-01-30
Last updated
2022-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TMD

Brief summary

TMD involves a set of multiple clinical manifestations where the pain is prevalent. Treatment ideally should be noninvasive and innocuous such as photobiomodulation

Interventions

patients from those diagnosed with TMD will receive Nd YAG laser 1064 nm

OTHERdiode laser (980 nm)

patients from those diagnosed with TMD will receive a diode laser (980 nm)

OTHERdiode laser (940 nm)

patients from those diagnosed with TMD will receive a diode laser (940 nm)

OTHERdiode laser (660 nm)

patients from those diagnosed with TMD will receive a diode laser (660 nm)

OTHERdiode laser (635 nm)

patients from those diagnosed with TMD will receive a diode laser (635 nm)

Sponsors

Hams Hamed Abdelrahman
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Pain at TMJ area. * Pain at masseter and temporalis muscles. * Age ranges between 20 and 40 years old. * Presence of full or nearly full complement of natural teeth

Exclusion criteria

* Patients who have radiographic evidence of degenerative conditions of TMJ. * Patients under current dental or physical therapy that could affect TMD. * History of recent trauma. * The presence of systemic diseases (i.e. rheumatoid arthritis, osteoarthritis). * Pregnant and lactating females

Design outcomes

Primary

MeasureTime frameDescription
Change in PainBaseline and 1 monthVisual analogue scale of pain (VAS),using a 0-10-point scale 0 score means no pain and score 10 means worst pain
Chaneg in pressure pain thresholdBaseline and 1 monthThe pressure pain threshold measurements for the trapezius, infraspinatus, and extensor carpi radialis muscles were performed at the center of the upper trapezius, at a position 2-3 fingers below the center of the spine of scapula, and at a position 3-4 fingers below the lateral epicondyle of the humerus, respectively. The pressure pain threshold of the extensor indicis proprius was measured by pressing toward the medial side of the radius from a position 3 fingers above the radial styloid process. The investigator placed the digital pressure algometer on a site to be inspected and pressed against the tester in a vertical direction while increasing the force at a constant rate of 1 kg/cm2. The investigator instructed the subjects to express pain either by saying ouch or raising their hands when only slight pain was felt. After all 8 muscles were investigated, the subjects were allowed to rest for 5 min. This procedure was repeated a total of 3 times.
Change in Oral-health Related Quality of life (OHRQoL)Baseline and 1 monthThe OHIP-14 has 14 questions related to the evaluation of OHRQoL. The responses were recorded in a 5-point Likert scale ranging from never to very often (score is 0 to 4). Then, we calculated the total scores of all domains, and a higher score indicated poor OHRQoL. The highest possible total score of all the OHIP-14 domains is 56

Countries

Egypt

Contacts

Primary ContactNermeen A Rady, phd
nermeen.rady@alexu.edu.eg01223349577

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026